SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine -- Ignore unavailable to you. Want to Upgrade?

To: Don W Stone who wrote (390)7/16/1998 12:34:00 AM
From: aknahow  Read Replies (1) | Respond to of 507
 
Don, Jessie Eisenger is a reporter. He is one of the best biotech reporters I have read. He is not saying short or buy NVX. He does a good job IMO of reporting what management is saying and what the shorts are saying. For example on Pharmucetlics (sp) he reports what shorts are saying. I as a reader do not think he means the shorts are right or wrong. I am interested in checking out the company. I want to know what the shorts are saying and why, before I buy any stock not after.

BTW Cramer does not edit the stories a Dave Kansas does. I have never seen something as well done as TSC, and I am your age.



To: Don W Stone who wrote (390)7/31/1998 1:53:00 AM
From: Mama Bear  Read Replies (2) | Respond to of 507
 
"Most of the shares shorted were shorted in the low teens and single digit numbers."

What are you talking about? My price history shows that the stock has not been in the single digits/low teens since the end of 1995/start of 1996. I think you're assuming something that isn't reasonable.

Barb


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News